Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Keratosis, Actinic 33Glioblastoma 20Brain Neoplasms 19Glioma 15Carcinoma, Basal Cell 9Skin Neoplasms 5Precancerous Conditions 5Astrocytoma 5Gliosarcoma 4Oligodendroglioma 3Mouth Neoplasms 3Carcinoma, Squamous Cell 3Squamous Intraepithelial Lesions 2Skull Base Neoplasms 2Skin Diseases 2Sarcoma 2Neoplasms 2Mycosis Fungoides 2Meningioma 2Lymphoma, T-Cell, Cutaneous 2Leukoplakia, Oral 2Head and Neck Neoplasms 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Pituitary Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 101liposomal doxorubicin 100Cyclophosphamide 96Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 40Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Aminolevulinic Acid × Clear all
NCT05804370 2025-10-01

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

NX Development Corp

Phase 3 Recruiting
170 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡